NASHVILLE, Tenn., Aug. 28, 2019 /PRNewswire/ -- IBM (NYSE: IBM) announced today the launch of

NEW PROVIDENCE, N.J., Aug. 28, 2019 /PRNewswire/ -- eNOVA — the next-generation medical communications company with a team dedicated to eVolutionizing™ customer engagement for Life Sciences — delivered 48 backpacks filled with all necessary school supplies to East Orange Campus High School on Monday,

SAN JUAN, Puerto Rico, Aug. 28, 2019 /PRNewswire/ -- Triple-S Management Corporation (NYSE: GTS) today announced that its President and Chief Executive Officer Roberto García-Rodríguez, and its EVP and Chief Financial Officer Juan José Román-Jiménez will participate in a fireside chat at the 2019 Wells Far

BRAINTREE, Mass., Aug. 28, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley's Annual Global Healthcare Conference in New York, NY on Monday, September 9, 2019 at 11:05am

ROCKVILLE, Md., Aug. 28, 2019 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq:RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, today announced that it will present at the following September investor conferences:Citi's 14th An

LOS ANGELES, Aug. 28, 2019 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (OTC: IMUC) today announced receipt of payment of $500,000 in conjunction with the completion of a transaction for the purchase of substantially all of ImmunoCellular's remaining assets, including its preclinical and clinical programs, technology,

SAN DIEGO, Aug. 28, 2019 /PRNewswire/ -- MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for its fiscal year ended June 30, 2019."It was a very productive year, with each of the four clinical-stage programs within our oncology portfolio adv

SAN DIEGO, Aug. 28, 2019 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that Neurocrine Biosciences management will present at the following investor conferences:Matt Abernethy, Chief Financial Officer, will present at the Baird 2019 Global Healthcare Conference at

BENTONVILLE, Ark., Aug. 28, 2019 /PRNewswire/ -- Glucose Health, Inc. (OTC: GLUC) confirms the following selected financial data for the period ended June 30, 2019, posted today at OTCMarkets.com.Revenue of $135,489 at June 30, 2019, compared with

MINNEAPOLIS, Aug. 28, 2019 /PRNewswire/ -- Can a person with multiple sclerosis (MS) get regular vaccines? According to a new guideline, the answer is yes. The guideline, developed by the